Skip to content

Study · Not a test of the peptide alone · 1996

5 results

[The antifungal and immunomodulating lymphotropic therapy of candidiasis of the oral mucosa].

Shumskiĭ AV, Pozharitskaia MM, Iurchenko EV

Stomatologiia1 Jan 1996

PMID8992656 (opens in a new tab)PepBankPUB-08992656
Publisher pageAsk about this study
Jump to 5 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone5

In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymogen (oglufanide).

  1. 01HumanNot a test of Thymogen (oglufanide) aloneNon-randomized trialEfficacy outcome

    In patients with oral candidiasis, the combined regimen containing thymogen normalized buccal mucosa status after treatment.

    In plain wordsIn patients with oral candidiasis, the combined regimen containing thymogen restored normal mouth lining after treatment.

    Peptide
    Thymogen (oglufanide)
    Outcome
    Not applicableBuccal mucosa status
    Study

    n = 52

    Outcome group
    Infection and antimicrobial activity · Infection

    Source sentences

    Summary
    The status of the buccal mucosa normalized after treatment.
    2 context sentences
    Summary · context
    Lymphotropic and endolymphatic therapy was carried out in 52 patients with candidiasis of the buccal mucosa.
    Summary · context
    Immunocorrector thymogen was injected in the submaxillary and chin lymph nodes.

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

  2. 02HumanNot a test of Thymogen (oglufanide) aloneNon-randomized trialEfficacy outcome

    In patients with oral candidiasis, the combined regimen containing thymogen decreased mucosal yeast contamination after treatment.

    In plain wordsIn patients with oral candidiasis, the combined regimen containing thymogen reduced yeast contamination after treatment.

    Peptide
    Thymogen (oglufanide)
    Outcome
    DecreaseMucosal yeast contamination
    Study

    n = 52

    Outcome group
    Infection and antimicrobial activity · Infection

    Source sentences

    Summary
    Contamination of the mucosa with yeast cells appreciably decreased
    2 context sentences
    Summary · context
    Lymphotropic and endolymphatic therapy was carried out in 52 patients with candidiasis of the buccal mucosa.
    Summary · context
    Immunocorrector thymogen was injected in the submaxillary and chin lymph nodes.

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

  3. 03HumanNot a test of Thymogen (oglufanide) aloneNon-randomized trialEfficacy outcome

    In patients with oral candidiasis, the combined regimen containing thymogen reduced salivary substances with medium molecular mass.

    In plain wordsIn patients with oral candidiasis, the combined regimen containing thymogen reduced medium-sized substances in saliva after treatment.

    Peptide
    Thymogen (oglufanide)
    Outcome
    DecreaseSalivary medium-molecular-mass substances
    Study

    n = 52

    Outcome group
    Infection and antimicrobial activity · Infection

    Source sentences

    Summary
    the content of substances with medium-molecular mass in the saliva reduced
    2 context sentences
    Summary · context
    Lymphotropic and endolymphatic therapy was carried out in 52 patients with candidiasis of the buccal mucosa.
    Summary · context
    Immunocorrector thymogen was injected in the submaxillary and chin lymph nodes.

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

  4. 04HumanNot a test of Thymogen (oglufanide) aloneNon-randomized trialEfficacy outcome

    In patients with oral candidiasis, the combined regimen containing thymogen normalized cellular immunity parameters.

    In plain wordsIn patients with oral candidiasis, the combined regimen containing thymogen restored normal cellular immune measures after treatment.

    Peptide
    Thymogen (oglufanide)
    Outcome
    Not applicableCellular immunity parameters
    Study

    n = 52

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    and cellular and humoral immunity parameters normalized.
    2 context sentences
    Summary · context
    Lymphotropic and endolymphatic therapy was carried out in 52 patients with candidiasis of the buccal mucosa.
    Summary · context
    Immunocorrector thymogen was injected in the submaxillary and chin lymph nodes.

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

  5. 05HumanNot a test of Thymogen (oglufanide) aloneNon-randomized trialEfficacy outcome

    In patients with oral candidiasis, the combined regimen containing thymogen normalized humoral immunity parameters.

    In plain wordsIn patients with oral candidiasis, the combined regimen containing thymogen restored normal antibody-related immune measures after treatment.

    Peptide
    Thymogen (oglufanide)
    Outcome
    Not applicableHumoral immunity parameters
    Study

    n = 52

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    and cellular and humoral immunity parameters normalized.
    2 context sentences
    Summary · context
    Lymphotropic and endolymphatic therapy was carried out in 52 patients with candidiasis of the buccal mucosa.
    Summary · context
    Immunocorrector thymogen was injected in the submaxillary and chin lymph nodes.

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.